Skip to main content
Top
Published in: Infection 6/2016

01-12-2016 | Original Paper

Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study

Authors: Roberto Luzzati, Maria Merelli, Filippo Ansaldi, Chiara Rosin, Annamaria Azzini, Silvia Cavinato, Pierluigi Brugnaro, Claudio Vedovelli, Annamaria Cattelan, Busetti Marina, Giuseppe Gatti, Ercole Concia, Matteo Bassetti

Published in: Infection | Issue 6/2016

Login to get access

Abstract

Purpose

Risk factors for nosocomial candidemia, severity of sepsis, treatment, and outcome were compared between patients admitted to medicine wards and those to surgical and intensive care units (ICUs).

Methods

Data were retrospectively collected from patients belonging to six referral hospitals in Italy between January 2011 and December 2013. Risk factors for 30-day mortality were evaluated in the whole patient population.

Results

A total of 686 patients (mean age 70 ± 15 years) with candidemia were included. 367 (53.5 %) patients were in medicine wards, and 319 in surgery and ICUs. Host-related risk factors for candidemia were more common in medicine patients whereas healthcare-related factors in surgery/ICU patients. These patients showed severe sepsis and septic shock more commonly (71.7 %) than medicine patients (59.9 %) (p 0.003). The latter underwent central venous catheter (CVC) removal and adequate antifungal therapy less frequently than surgery/ICU patients. 149 (40.6 %) patients died with candidemia in medicine wards and 69 (21.6 %) in other wards (p < 0.001). Overall, the 30-day mortality was 36.3 %. At multivariate analysis, independent risk factors for death were aging, higher Charlson score, severe sepsis and septic shock, and no antifungal therapy, while major surgery and CVC removal were associated with higher probability of survival.

Conclusions

The burden of risk factors for candidemia was different between medicine patients and those in other wards. Despite the lower severity of candidemia in medicine patients, their mortality turned out to be higher than in surgery or ICU patients. Awareness of the best management of candidemia should be pursued, especially in medicine wards.
Literature
1.
go back to reference Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20:1149–55.CrossRefPubMed Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20:1149–55.CrossRefPubMed
2.
go back to reference Wisplinghoff H, Ebbers J, Geurt J, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43:78–81.CrossRefPubMed Wisplinghoff H, Ebbers J, Geurt J, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43:78–81.CrossRefPubMed
3.
go back to reference Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.CrossRefPubMed Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.CrossRefPubMed
4.
go back to reference Bassetti M, Molinari MP, Mussap M, Viscoli C, Righi E. Candidemia in internal medicine departments: the burden of a rising problem. Clin Microb Infect. 2013;19:E281–4.CrossRef Bassetti M, Molinari MP, Mussap M, Viscoli C, Righi E. Candidemia in internal medicine departments: the burden of a rising problem. Clin Microb Infect. 2013;19:E281–4.CrossRef
5.
go back to reference Luzzati R, Cavinato S, Deiana ML, Rosin C, Maurel C, Borelli M. Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res. 2015;27:131–7.CrossRefPubMed Luzzati R, Cavinato S, Deiana ML, Rosin C, Maurel C, Borelli M. Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res. 2015;27:131–7.CrossRefPubMed
6.
go back to reference De Rosa FG, Corcione S, Filippini S, et al. The effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards. PLoS One. 2015;10:e0125149.CrossRefPubMedPubMedCentral De Rosa FG, Corcione S, Filippini S, et al. The effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards. PLoS One. 2015;10:e0125149.CrossRefPubMedPubMedCentral
7.
go back to reference Nieto MC, Telleria O, Cisterna R. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility. Diagn Microbiol Infect Dis. 2015;81:34–40.CrossRefPubMed Nieto MC, Telleria O, Cisterna R. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility. Diagn Microbiol Infect Dis. 2015;81:34–40.CrossRefPubMed
8.
go back to reference Lortholary O, Ranaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014;40:1303–12.CrossRefPubMedPubMedCentral Lortholary O, Ranaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014;40:1303–12.CrossRefPubMedPubMedCentral
9.
go back to reference Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microb Rev. 2007;20:133–63.CrossRef Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microb Rev. 2007;20:133–63.CrossRef
10.
go back to reference European Committee on Antimicrobial Susceptibility Test. Antimicrobials for Candida infections-EUCAST clinical MIC breakpoints. 2013;2013-03-11 (v 6.1). European Committee on Antimicrobial Susceptibility Test. Antimicrobials for Candida infections-EUCAST clinical MIC breakpoints. 2013;2013-03-11 (v 6.1).
11.
go back to reference Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference Committee. American College of Chest Physician/Society of Critical Care Medicine. Chest. 1992;101:1644–55.CrossRefPubMed Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference Committee. American College of Chest Physician/Society of Critical Care Medicine. Chest. 1992;101:1644–55.CrossRefPubMed
12.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
14.
go back to reference Guimaraes T, Nucci M, Mendonca JS, et al. Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis. 2012;16:e442–7.CrossRefPubMed Guimaraes T, Nucci M, Mendonca JS, et al. Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis. 2012;16:e442–7.CrossRefPubMed
15.
go back to reference Wang H, Liu N, Yin M, et al. The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study. BMC Infect Dis. 2014;14:609.CrossRefPubMedPubMedCentral Wang H, Liu N, Yin M, et al. The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study. BMC Infect Dis. 2014;14:609.CrossRefPubMedPubMedCentral
16.
go back to reference Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:685–702.CrossRefPubMed Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:685–702.CrossRefPubMed
17.
go back to reference Bassetti M, Merelli M, Righi E, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microb. 2013;51:4167–72.CrossRef Bassetti M, Merelli M, Righi E, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microb. 2013;51:4167–72.CrossRef
18.
go back to reference De Rosa GF, Trecarichi EM, Montrucchio C, et al. Mortality in patients with early- and late-onset candidaemia. J Antimicrob Chemother. 2013;68:927–35.CrossRefPubMed De Rosa GF, Trecarichi EM, Montrucchio C, et al. Mortality in patients with early- and late-onset candidaemia. J Antimicrob Chemother. 2013;68:927–35.CrossRefPubMed
19.
go back to reference Castle SC, Uyemura K, Fulop T, Mafinodan T. Host resistance and immune responses in advanced age. Clin Geriatr. 2007;23:463–79.CrossRef Castle SC, Uyemura K, Fulop T, Mafinodan T. Host resistance and immune responses in advanced age. Clin Geriatr. 2007;23:463–79.CrossRef
20.
go back to reference Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20:5–10.CrossRef Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20:5–10.CrossRef
21.
go back to reference Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol. 2002;40:3551–7.CrossRefPubMedPubMedCentral Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol. 2002;40:3551–7.CrossRefPubMedPubMedCentral
22.
go back to reference Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: sentry antimicrobial surveillance program, 1997 to 2000. J Clin Microbiol. 2002;40:852–6.CrossRefPubMedPubMedCentral Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: sentry antimicrobial surveillance program, 1997 to 2000. J Clin Microbiol. 2002;40:852–6.CrossRefPubMedPubMedCentral
23.
go back to reference Pfaller MA, Boyken L, Hollis RJ, et al. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis. 2009;25:27–34.CrossRef Pfaller MA, Boyken L, Hollis RJ, et al. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis. 2009;25:27–34.CrossRef
24.
go back to reference Messer SA, Moet GJ, Kirby JT, Jones RN. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J Clin Microbiol. 2009;47:1942–6.CrossRefPubMedPubMedCentral Messer SA, Moet GJ, Kirby JT, Jones RN. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J Clin Microbiol. 2009;47:1942–6.CrossRefPubMedPubMedCentral
25.
go back to reference Luzzati R, Cavinato S, Giangreco M, et al. Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case–control study. Mycoses. 2013;56:664–71.CrossRefPubMed Luzzati R, Cavinato S, Giangreco M, et al. Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case–control study. Mycoses. 2013;56:664–71.CrossRefPubMed
26.
go back to reference Tascini C, Sozio S, Tintori C, et al. Peripherally inserted central catheter as a predominant risk factor for candidemia in critically ill patients in internal medicine wards in Italy. Intensive Care Med. 2015;41:1498–9.CrossRefPubMed Tascini C, Sozio S, Tintori C, et al. Peripherally inserted central catheter as a predominant risk factor for candidemia in critically ill patients in internal medicine wards in Italy. Intensive Care Med. 2015;41:1498–9.CrossRefPubMed
27.
go back to reference Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology a predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20:O245–54.CrossRefPubMed Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology a predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20:O245–54.CrossRefPubMed
28.
go back to reference Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.CrossRefPubMed Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.CrossRefPubMed
29.
go back to reference Cornely OA, Bassetti M, Calandra T, ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases non-neutropenic adult patients. Clin Microb Infect. 2012;18:19–37.CrossRef Cornely OA, Bassetti M, Calandra T, ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases non-neutropenic adult patients. Clin Microb Infect. 2012;18:19–37.CrossRef
30.
go back to reference Scudeller L, Viscoli C, Menichetti F, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263–79.CrossRefPubMed Scudeller L, Viscoli C, Menichetti F, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263–79.CrossRefPubMed
31.
go back to reference Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other form of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110–22.CrossRefPubMed Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other form of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110–22.CrossRefPubMed
32.
go back to reference Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40:839–45.CrossRefPubMed Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40:839–45.CrossRefPubMed
33.
go back to reference Murri R, Scoppettuolo G, Ventura G, et al. Initial antifungal strategy does not correlate with mortality in patients with candide mia. Eur J Clin Microb. 2015;35:187–93.CrossRef Murri R, Scoppettuolo G, Ventura G, et al. Initial antifungal strategy does not correlate with mortality in patients with candide mia. Eur J Clin Microb. 2015;35:187–93.CrossRef
34.
go back to reference Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Sociey of America. Clin Infect Dis. 2016;62:e1–50.CrossRefPubMed Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Sociey of America. Clin Infect Dis. 2016;62:e1–50.CrossRefPubMed
Metadata
Title
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study
Authors
Roberto Luzzati
Maria Merelli
Filippo Ansaldi
Chiara Rosin
Annamaria Azzini
Silvia Cavinato
Pierluigi Brugnaro
Claudio Vedovelli
Annamaria Cattelan
Busetti Marina
Giuseppe Gatti
Ercole Concia
Matteo Bassetti
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0924-9

Other articles of this Issue 6/2016

Infection 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.